Article Details
Retrieved on: 2025-09-14 14:48:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The findings, delivered by Dr. Matthew Lorincz, emphasize the long-term neurological efficacy and safety of ALXN1840, with median treatment duration ...
Article found on: www.quiverquant.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here